No Data
No Data
LBT Innovations Sells APAS Independence Instrument to NovaCina
LBT Innovations (ASX:LBT) agreed to the direct sale of APAS Independence, together with the APAS PharmaQC annual software license and maintenance and support services, to development and manufacturing
Australian Shares Track Gains of Wall Street Peers as Market Shrugs Off US Inflation Data
Australian shares on Wednesday tracked the gains of their Wall Street peers, which rallied despite the stronger-than-expected US inflation data. The S&P/ASX 200 Index rose 16.90 points, or 0.2%, to 7,
LBT Innovations Confirms APAS PharmaQC Ready for Sale to Global Biopharma Markets
LBT Innovations (ASX: LBT) has announced that its APAS (Automated Plate Assessment System) PharmaQC technology for automated imaging, analysis and interpretation of microbiology culture plates is ready for sale to global markets.
LBT Innovations' APAS PharmaQC Completes Primary Validation; Shares Up 79%
Medical technology company LBT Innovations (ASX:LBT) completed primary validation for its APAS PharmaQC product, according to a Wednesday filing with the Australian Securities Exchange. The technology
Stocks of the Hour: ABx Group, LBT Innovations, NickelSearch
To register for Friday's webinar click here.ABx Group (ASX:ABX) announced high-grade rare-earth elements results from the recently completed 97-hole drilling campaign at Rubble Mound. The results enla
LBT Innovations Delivers APAS Hardware, Software to Thermo Fisher
LBT Innovations (ASX:LBT) has delivered an APAS Independence instrument, along with APAS PharmaQC software, to Nasdaq-listed biotechnology firm Thermo Fisher Scientific. That delivery was part of a st
No Data